BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29469775)

  • 1. Coexistence of keloids and pilomatricoma in a patient with Rubinstein-Taybi syndrome.
    Yagi Y; Kuwatsuka Y; Asai M; Honda M; Utani A
    Dermatol Online J; 2018 Jan; 24(1):. PubMed ID: 29469775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rubinstein-Taybi syndrome with multiple flamboyant keloids.
    Hendrix JD; Greer KE
    Cutis; 1996 May; 57(5):346-8. PubMed ID: 8726717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keloids in Rubinstein-Taybi syndrome: a clinical study.
    van de Kar AL; Houge G; Shaw AC; de Jong D; van Belzen MJ; Peters DJ; Hennekam RC
    Br J Dermatol; 2014 Sep; 171(3):615-21. PubMed ID: 25132000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome.
    Bueno ALA; de Souza MEV; Graziadio C; Kiszewski AE
    An Bras Dermatol; 2020; 95(5):619-622. PubMed ID: 32778355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilomatrixomas in Rubinstein-Taybi syndrome.
    Masuno M; Imaizumi K; Ishii T; Kuroki Y; Baba N; Tanaka Y
    Am J Med Genet; 1998 Apr; 77(1):81-2. PubMed ID: 9557902
    [No Abstract]   [Full Text] [Related]  

  • 6. Dermatological findings in Rubinstein-Taybi Syndrome.
    Cammarata-Scalisi F; Diociaiuti A; Cárdenas Tadich A; Sandoval X; Oranges T; Filippeschi C; Araya Castillo M; Willoughby CE; Cerri A; Gervasini C; Callea M
    Ital J Dermatol Venerol; 2023 Aug; 158(4):316-320. PubMed ID: 37282850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rubinstein-Taybi syndrome with multiple keloids].
    Sammartino A; Cerbella R; Lembo G; Federico A; Loffredo L
    J Fr Ophtalmol; 1986; 9(11):725-9. PubMed ID: 3571836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keloids: an unwanted spontaneity in rubinstein-taybi syndrome.
    Shilpashree P; Jaiswal AK; Kharge PM
    Indian J Dermatol; 2015; 60(2):214. PubMed ID: 25814745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rubinstein-Taybi syndrome and spontaneous keloids.
    Goodfellow A; Emmerson RW; Calvert HT
    Clin Exp Dermatol; 1980 Sep; 5(3):369-70. PubMed ID: 7438534
    [No Abstract]   [Full Text] [Related]  

  • 10. Rubinstein-Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction.
    Hallam TM; Bourtchouladze R
    Cell Mol Life Sci; 2006 Aug; 63(15):1725-35. PubMed ID: 16786226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rubinstein-Taybi syndrome with multiple pilomatricomas: The first case diagnosed by CREBBP mutation analysis.
    Rokunohe D; Nakano H; Akasaka E; Toyomaki Y; Sawamura D
    J Dermatol Sci; 2016 Sep; 83(3):240-2. PubMed ID: 27342041
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple pilomatricomas in Rubinstein-Taybi syndrome: a case report.
    Cambiaghi S; Ermacora E; Brusasco A; Canzi L; Caputo R
    Pediatr Dermatol; 1994 Mar; 11(1):21-5. PubMed ID: 8170843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rubinstein-Taybi syndrome with normal FISH result and CREBBP gene analysis: a case report.
    Balci S; Ergün MA; Yüksel-Konuk EB; Bartsch O
    Turk J Pediatr; 2008; 50(3):265-8. PubMed ID: 18773673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the Editor: A Novel Mutation in the CREBBP Gene of a Korean Girl with Rubinstein-Taybi syndrome.
    Huh R; Cho SY; Kim J; Ki CS; Jin DK
    Ann Clin Lab Sci; 2015; 45(4):458-61. PubMed ID: 26275701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rubinstein-Taybi syndrome. Cutaneous manifestations and colossal keloids.
    Selmanowitz VJ; Stiller MJ
    Arch Dermatol; 1981 Aug; 117(8):504-6. PubMed ID: 7259246
    [No Abstract]   [Full Text] [Related]  

  • 16. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas.
    Xia J; Urabe K; Moroi Y; Koga T; Duan H; Li Y; Furue M
    J Dermatol Sci; 2006 Jan; 41(1):67-75. PubMed ID: 16378715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in microdeletions of the cyclic AMP-responsive element-binding protein gene at chromosome band 16p13.3 in the Rubinstein-Taybi syndrome.
    Blough RI; Petrij F; Dauwerse JG; Milatovich-Cherry A; Weiss L; Saal HM; Rubinstein JH
    Am J Med Genet; 2000 Jan; 90(1):29-34. PubMed ID: 10602114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rubinstein-Taybi syndrome predisposing to non-WNT, non-SHH, group 3 medulloblastoma.
    Bourdeaut F; Miquel C; Richer W; Grill J; Zerah M; Grison C; Pierron G; Amiel J; Krucker C; Radvanyi F; Brugieres L; Delattre O
    Pediatr Blood Cancer; 2014 Feb; 61(2):383-6. PubMed ID: 24115570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keloids and neoplasms in the Rubinstein-Taybi syndrome.
    Siraganian PA; Rubinstein JH; Miller RW
    Med Pediatr Oncol; 1989; 17(6):485-91. PubMed ID: 2586363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral congenital corneal keloids and anterior segment mesenchymal dysgenesis in a case of Rubinstein-Taybi syndrome.
    Rao SK; Fan DS; Pang CP; Li WW; Ng JS; Good WV; Lam DS
    Cornea; 2002 Jan; 21(1):126-30. PubMed ID: 11805525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.